10 results on '"Jon I. Quintana"'
Search Results
2. Galectin-4 N-Terminal Domain: Binding Preferences Toward A and B Antigens With Different Peripheral Core Presentations
- Author
-
Jon I. Quintana, Sandra Delgado, Reyes Núñez-Franco, F. Javier Cañada, Gonzalo Jiménez-Osés, Jesús Jiménez-Barbero, and Ana Ardá
- Subjects
NMR ,molecular recognition ,galectin-4 ,blood type antigen ,lectin—carbohydrate interaction ,Chemistry ,QD1-999 - Abstract
The tandem-repeat Galectin-4 (Gal-4) contains two different domains covalently linked through a short flexible peptide. Both domains have been shown to bind preferentially to A and B histo blood group antigens with different affinities, although the binding details are not yet available. The biological relevance of these associations is unknown, although it could be related to its attributed role in pathogen recognition. The presentation of A and B histo blood group antigens in terms of peripheral core structures differs among tissues and from that of the antigen-mimicking structures produced by pathogens. Herein, the binding of the N-terminal domain of Gal-4 toward a group of differently presented A and B oligosaccharide antigens in solution has been studied through a combination of NMR, isothermal titration calorimetry (ITC), and molecular modeling. The data presented in this paper allow the identification of the specific effects that subtle chemical modifications within this antigenic family have in the binding to the N-terminal domain of Gal-4 in terms of affinity and intermolecular interactions, providing a structural-based rationale for the observed trend in the binding preferences.
- Published
- 2021
- Full Text
- View/download PDF
3. Targeting Galectins With Glycomimetics
- Author
-
Sara Bertuzzi, Jon I. Quintana, Ana Ardá, Ana Gimeno, and Jesús Jiménez-Barbero
- Subjects
galectins ,glycomimetics ,glycans ,molecular recogntion ,drug design ,Chemistry ,QD1-999 - Abstract
Among glycan-binding proteins, galectins, β-galactoside-binding lectins, exhibit relevant biological roles and are implicated in many diseases, such as cancer and inflammation. Their involvement in crucial pathologies makes them interesting targets for drug discovery. In this review, we gather the last approaches toward the specific design of glycomimetics as potential drugs against galectins. Different approaches, either using specific glycomimetic molecules decorated with key functional groups or employing multivalent presentations of lactose and N-acetyl lactosamine analogs, have provided promising results for binding and modulating different galectins. The review highlights the results obtained with these approximations, from the employment of S-glycosyl compounds to peptidomimetics and multivalent glycopolymers, mostly employed to recognize and/or detect hGal-1 and hGal-3.
- Published
- 2020
- Full Text
- View/download PDF
4. Novel NMR Avenues to Explore the Conformation and Interactions of Glycans
- Author
-
José I. Santos, Jesús Jiménez-Barbero, Ana Ardá, Pablo Valverde, and Jon I. Quintana
- Subjects
Glycan ,biology ,010405 organic chemistry ,Chemistry ,General Chemical Engineering ,General Chemistry ,Computational biology ,010402 general chemistry ,01 natural sciences ,0104 chemical sciences ,Molecular recognition ,Perspective ,biology.protein ,Glycan, Molecular Recognition, NMR, Interactions ,QD1-999 - Abstract
This perspective article is focused on the presentation of the latest advances in NMR methods and applications that are behind the exciting achievements in the understanding of glycan receptors in molecular recognition events. Different NMR-based methodologies are discussed along with their applications to scrutinize the conformation and dynamics of glycans as well as their interactions with protein receptors.
- Published
- 2019
5. Recent advances in the application of NMR methodologies to analyze the conformation, dynamics, and interactions of saccharides
- Author
-
J. D. Martínez, Ana Ardá, Pablo Valverde, Jesús Jiménez-Barbero, M. G. Lete, Ana Poveda, Maria Pia Lenza, F. J. Cañada, Ana Gimeno, B. Fernández de Toro, M. Gómez-Redondo, M. J. Moure, Unai Atxabal, Sara Bertuzzi, Jon I. Quintana, Antonio Franconetti, June Ereño-Orbea, Ángeles Canales, Ministerio de Economía y Competitividad (España), Ardá, Ana, Bertuzzi, Sara, Canales, A., Cañada, F. Javier, Franconetti, Antonio, Jiménez-Barbero, Jesús, Ardá, Ana [0000-0003-3027-7417], Bertuzzi, Sara [0000-0002-4242-7067], Canales, A. [0000-0003-0542-3080], Cañada, F. Javier [0000-0003-4462-1469], Franconetti, Antonio [0000-0002-7972-8795], and Jiménez-Barbero, Jesús [0000-0001-5421-8513]
- Subjects
Molecular recognition ,Computational chemistry ,Chemistry ,Molecule - Abstract
25 p.-7 fig. Carbohydrate Chemistry: Chemical and Biological Approaches.Volume 44. Editors: Amélia Pilar Rauter, Thisbe K Lindhorst, Yves Queneau, This chapter is dedicated to the presentation of different examples of the application of solution NMR to the study of conformation, dynamics of sugar molecules (oligo and polysaccharides, glycopeptides and glycomimetics) including the investigation of glycanrelated molecular recognition events. It is not our intention to be exhaustive, rather to highlight diverse examples since 2016. They are presented depending on the chemical nature of the saccharide molecule, and on the different methodologies that can be employed., We thank MINECO (Spain, Projects) and the European Union (Project RECGLYCANMR and BACTIVAX) for financial support. AF also thanksMINECO for Juan de la Cierva contract.
- Published
- 2020
6. Structure-guided design of a Group B Streptococcus type III synthetic glycan-conjugate vaccine
- Author
-
Davide Oldrini, Linda del Bino, Ana Ardá, Filippo Carboni, Pedro Henriques, Francesca Angiolini, Jon I. Quintana, Ilaria Calloni, Maria R. Romano, Francesco Berti, Jesus Jimenez- Barbero, Immaculada Margarit, and Roberto Adamo
- Subjects
Glycan, Molecular Recognition, NMR , interactions - Abstract
We recently mapped the structural epitope of the capsular polysaccharide from type III Group B Streptococcus (GBSIII), a major cause of invasive disease in newborns, by using a dimer fragment obtained by depolymerization complexed with a protective mAb. While literature data had suggested a highly complex epitope contained in a helical structure composed of more than four repeating units, we showed that such dimer conjugated to a carrier protein with a high glycodensity elicited functional antibodies comparably to the full-length conjugated polysaccharide. Here, starting from the X-ray crystallographic structure of the polysaccharide fragment-mAb complex, we designed and synthesized a hexasaccharide comprising exclusively the relevant positions involved in binding. Combining competitive Surface Plasmon Resonance, Saturation Transfer Difference NMR and in silico modelling, we demonstrated that the synthetic hexasaccharide recognized the mAb similarly to the dimer and, conjugated to CRM197 (a mutant of diphtheria toxin), elicited a functional immune response non inferior to the conjugated polysaccharide, indicating to suffice as vaccine antigen
- Published
- 2020
7. Structure‐guided design of a Group B Streptococcus type III synthetic glycan‐conjugate vaccine
- Author
-
Francesca Angiolini, Maria Rosaria Romano, Jesús Jiménez-Barbero, Linda del Bino, Francesco Berti, Pedro Henriques, Filippo Carboni, Jon I. Quintana, Ilaria Calloni, Immaculada Margarit, Davide Oldrini, Ana Ardá, and Roberto Adamo
- Subjects
carbohydrates ,Library science ,010402 general chemistry ,01 natural sciences ,Catalysis ,Streptococcus agalactiae ,immunology ,Epitopes ,03 medical and health sciences ,Bacterial Proteins ,Conjugate vaccine ,Polysaccharides ,Tactical plan ,Humans ,030304 developmental biology ,Vaccines, Synthetic ,0303 health sciences ,Vaccines, Conjugate ,Full Paper ,Chemistry ,010405 organic chemistry ,Organic Chemistry ,streptococcus ,General Chemistry ,Full Papers ,vaccines ,glycoconjugates ,3. Good health ,0104 chemical sciences ,structural glycobiology ,Alliance ,Glycoconjugates | Very Important Paper ,Research center - Abstract
Identification of glycan functional epitopes is of paramount importance for rational design of glycoconjugate vaccines. We recently mapped the structural epitope of the capsular polysaccharide from type III Group B Streptococcus (GBSIII), a major cause of invasive disease in newborns, by using a dimer fragment (composed of two pentasaccharide repeating units) obtained by depolymerization complexed with a protective mAb. Although reported data had suggested a highly complex epitope contained in a helical structure composed of more than four repeating units, we showed that such dimer conjugated to a carrier protein with a proper glycosylation degree elicited functional antibodies comparably to the full‐length conjugated polysaccharide. Here, starting from the X‐ray crystallographic structure of the polysaccharide fragment–mAb complex, we synthesized a hexasaccharide comprising exclusively the relevant positions involved in binding. Combining competitive surface plasmon resonance and saturation transfer difference NMR spectroscopy as well as in‐silico modeling, we demonstrated that this synthetic glycan was recognized by the mAb similarly to the dimer. The hexasaccharide conjugated to CRM197, a mutant of diphtheria toxin, elicited a robust functional immune response that was not inferior to the polysaccharide conjugate, indicating that it may suffice as a vaccine antigen. This is the first evidence of an X‐ray crystallography‐guided design of a synthetic carbohydrate‐based conjugate vaccine., Deciphering the sugar glycocode: Starting from the X‐ray crystallographic structure of a fragment from Group B Streptococcus type III capsular polysaccharide in complex with a protective mAb complex, a hexasaccharide comprising exclusively the relevant positions involved in interactions was obtained. By structural and immunogenicity studies it was shown that the synthetic hexasaccharide recognized the mAb similarly to the polysaccharide fragment and, conjugated to a carrier protein, suffices as vaccine antigen.
- Published
- 2020
- Full Text
- View/download PDF
8. Structural Characterization of N-Linked Glycans in the Receptor Binding Domain of the SARS-CoV-2 Spike Protein and their Interactions with Human Lectins
- Author
-
June Ereño-Orbea, Tammo Diercks, Maria Pia Lenza, Mikel Valle, Gonzalo Jiménez-Osés, Helena Coelho, Filipa Marcelo, Francesca Peccati, Ana Gimeno, Asis Palazon, Alexandre Bosch, Ana Ardá, Jesús Jiménez-Barbero, Ana Diniz, Oscar Millet, Iker Oyenarte, Sandra Delgado, Jon I. Quintana, Nicola G. A. Abrescia, European Commission, UCIBIO - Applied Molecular Biosciences Unit, and DQ - Departamento de Química
- Subjects
Models, Molecular ,Glycosylation ,Chemistry(all) ,Plasma protein binding ,01 natural sciences ,Epitope ,chemistry.chemical_compound ,NMR-spectroscopy ,antibodies ,Research Articles ,glycoproteins ,chemistry.chemical_classification ,glycan ,receptor binding domain ,biology ,Chemistry ,lacdinac ,General Medicine ,Nuclear magnetic resonance spectroscopy ,Biochemistry ,Spike Glycoprotein, Coronavirus ,Angiotensin-Converting Enzyme 2 ,recognition ,Research Article ,Protein Binding ,Glycan ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,010402 general chemistry ,Catalysis ,Molecular recognition ,galectin-8 ,Molecular Recognition | Very Important Paper ,Polysaccharides ,expression ,Humans ,Lectins, C-Type ,Nuclear Magnetic Resonance, Biomolecular ,Galectin ,SARS-CoV-2 ,010405 organic chemistry ,ligands ,HEK 293 cells ,Lectin ,General Chemistry ,0104 chemical sciences ,HEK293 Cells ,SARS-CoV2 ,biology.protein ,NMR, MOLECULAR RECOGNITION, LECTIN, GLYCAN, SPIKE, SARS COV-2 ,lectin ,identification ,affinity ,molecular recognition ,Glycoprotein ,Receptors, Coronavirus - Abstract
The glycan structures of the receptor binding domain of the SARS‐CoV2 spike glycoprotein expressed in human HEK293F cells have been studied by using NMR. The different possible interacting epitopes have been deeply analysed and characterized, providing evidence of the presence of glycan structures not found in previous MS‐based analyses. The interaction of the RBD 13C‐labelled glycans with different human lectins, which are expressed in different organs and tissues that may be affected during the infection process, has also been evaluated by NMR. In particular, 15N‐labelled galectins (galectins‐3, ‐7 and ‐8 N‐terminal), Siglecs (Siglec‐8, Siglec‐10), and C‐type lectins (DC‐SIGN, MGL) have been employed. Complementary experiments from the glycoprotein perspective or from the lectin's point of view have permitted to disentangle the specific interacting epitopes in each case. Based on these findings, 3D models of the interacting complexes have been proposed., Unprecedent structural details of the glycans of the RBD of SARS‐CoV‐2 spike glycoprotein have been revealed by NMR spectroscopy. Unexpected and non‐previously reported glycoepitopes have been detected. The interaction of the RBD glycoprotein with diverse human lectins has been scrutinised by exploiting the NMR signature of the 13C‐glycans. Our analysis permitted to identify the corresponding glycan epitopes responsible for the interaction with each lectin.
- Published
- 2020
9. Front Cover: Structure‐Guided Design of a Group B Streptococcus Type III Synthetic Glycan–Conjugate Vaccine (Chem. Eur. J. 31/2020)
- Author
-
Filippo Carboni, Linda del Bino, Francesca Angiolini, Maria Rosaria Romano, Jon I. Quintana, Jesús Jiménez-Barbero, Ilaria Calloni, Ana Ardá, Pedro Henriques, Immaculada Margarit, Roberto Adamo, Davide Oldrini, and Francesco Berti
- Subjects
chemistry.chemical_classification ,Glycan ,biology ,Glycoconjugate ,Stereochemistry ,Streptococcus ,Organic Chemistry ,General Chemistry ,medicine.disease_cause ,Catalysis ,Group B ,Front cover ,chemistry ,Conjugate vaccine ,biology.protein ,medicine - Published
- 2020
10. Exploring multivalent carbohydrate–protein interactions by NMR
- Author
-
Jon I. Quintana, Unai Atxabal, Luca Unione, Ana Ardá, and Jesús Jiménez-Barbero
- Subjects
General Chemistry - Abstract
Nuclear Magnetic Resonance (NMR) has been widely employed to assess diverse features of glycan–protein molecular recognition events. Different types of qualitative and quantitative information at different degrees of resolution and complexity can be extracted from the proper application of the available NMR-techniques. In fact, affinity, structural, kinetic, conformational, and dynamic characteristics of the binding process are available. Nevertheless, except in particular cases, the affinity of lectin-sugar interactions is weak, mostly at the low mM range. This feature is overcome in biological processes by using multivalency, thus augmenting the strength of the binding. However, the application of NMR methods to monitor multivalent lectin–glycan interactions is intrinsically challenging. It is well known that when large macromolecular complexes are formed, the NMR signals disappear from the NMR spectrum, due to the existence of fast transverse relaxation, related to the large size and exchange features. Indeed, at the heart of the molecular recognition event, the associated free-bound chemical exchange process for both partners takes place in a particular timescale. Thus, these factors have to be considered and overcome. In this review article, we have distinguished, in a subjective manner, the existence of multivalent presentations in the glycan or in the lectin. From the glycan perspective, we have also considered whether multiple epitopes of a given ligand are presented in the same linear chain of a saccharide (i.e., poly-LacNAc oligosaccharides) or decorating different arms of a multiantennae scaffold, either natural (as in multiantennae N-glycans) or synthetic (of dendrimer or polymer nature). From the lectin perspective, the presence of an individual binding site at every monomer of a multimeric lectin may also have key consequences for the binding event at different levels of complexity. We thank generous funding by the European Research Council (RECGLYCANMR, Advanced Grant No. 788143), the Agencia Estatal de Investigación (Spain) for grant PDI2021-1237810B-C21, and CIBERES, an initiative of Instituto de Salud Carlos III (ISCIII), Madrid, Spain. We also thank Marie-Skłodowska-Curie actions (TN BactiVax, under grant agreement No. 860325).
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.